1. Home
  2. PRHI vs BCDA Comparison

PRHI vs BCDA Comparison

Compare PRHI & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PRHI

Presurance Holdings Inc.

HOLD

Current Price

$7.00

Market Cap

18.7M

Sector

Finance

ML Signal

HOLD

Logo BioCardia Inc.

BCDA

BioCardia Inc.

HOLD

Current Price

$0.93

Market Cap

15.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRHI
BCDA
Founded
2009
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.7M
15.7M
IPO Year
2015
2009

Fundamental Metrics

Financial Performance
Metric
PRHI
BCDA
Price
$7.00
$0.93
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $15.50
AVG Volume (30 Days)
20.2K
★ 134.6K
Earning Date
11-11-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.66
N/A
Revenue
★ $43,304,000.00
$479,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.39
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.59
$0.75
52 Week High
$11.34
$1.80

Technical Indicators

Market Signals
Indicator
PRHI
BCDA
Relative Strength Index (RSI) 43.97 42.25
Support Level $4.05 $0.82
Resistance Level $7.95 $0.99
Average True Range (ATR) 0.80 0.08
MACD -0.11 -0.01
Stochastic Oscillator 18.32 26.97

Price Performance

Historical Comparison
PRHI
BCDA

About PRHI Presurance Holdings Inc.

Presurance Holdings Inc is an insurance holding company that markets and services product offerings through specialty personal insurance lines of business. Through its personal insurance lines, it offers homeowners insurance and dwelling fire insurance products to individuals in several states. The specialty homeowners insurance product line is comprised of low-value dwelling insurance tailored for owners of lower valued homes, which it offers in Texas, Illinois and Indiana. Through commercial insurance lines, it offers coverage for both commercial property and commercial liability and also offered coverage for commercial automobiles and workers' compensation. Its revenues are derived from premiums earned from insurance operations.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: